Novo Nordisk has been swept up in uncertainty around U.S. tariffs and Washington’s push to get firms to lower drug prices and move manufacturing stateside.
Novo Nordisk has been swept up in uncertainty around U.S. tariffs and Washington’s push to get firms to lower drug prices and move manufacturing stateside.
